Back to Authors

Zhu, Yun

https://orcid.org/0000-0002-0421-8643

Mayo Clinic

University of Hong Kong

Citations 3

Author response: NFATc2 enhances tumor-initiating phenotypes through the NFATc2/SOX2/ALDH axis in lung adenocarcinoma
Xiao, Zhijie , Zhu, Yun , Gao, Xuyuan , Tin, Vicky Pui‐Chi, Wong, Maria Pik , Liu, Jing , Wang, Siqi , Qin, Jing , Wang, Junwen , Wong, Maria Pik

No container title available | August 24, 2017 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.7554/elife.26733.032 Get It

NFATc2 enhances tumor-initiating phenotypes through the NFATc2/SOX2/ALDH axis in lung adenocarcinoma
Xiao, Zhijie , Wang, Si-Qi, Zhu, Yun , Gao, Xu-Yuan, Tin, Vicky Pui‐Chi, Qin, Jing , Wang, Junwen , Wong, Maria Pik , Xiao, Zhi-Jie , Wang, Jun-Wen, Wong, Maria Pik , Liu, Jing , Gao, Xu-Yuan, Wang, Junwen , Qin, Jing

eLife | July 24, 2017 | Volume: 6 | Issue: No issue available | Pages: No page available

10.7554/elife.26733 Get It

Tumor-initiating cells (TIC) are dynamic cancer cell subsets that display enhanced tumor functions and resilience to treatment but the mechanism of TIC induction or maintenance in lung cancer is not fully understood. In this study, we show the calcium pathway transcription factor NFATc2 is a novel regulator of lung TIC phenotypes, including tumorspheres, cell motility, tumorigenesis, as well as in vitro and in vivo responses to chemotherapy and targeted therapy. In human lung cancers, high NFATc2 expression predicted poor tumor differentiation, adverse recurrence-free and cancer-specific overall survivals. Mechanistic investigations identified NFATc2 response elements in the 3’ enhancer region of SOX2, and NFATc2/SOX2 coupling upregulates ALDH1A1 by binding to its 5’ enhancer. Through this axis, oxidative stress induced by cancer drug treatment is attenuated, leading to increased resistance in a mutation-independent manner. Targeting this axis provides a novel approach for the long-term treatment of lung cancer through TIC elimination.
Predicting regulatory variants with composite statistic
Li, Mulin Jun , Liu, Zipeng , Wu, Jiexing , Wang, Panwen , Zhu, Yun , Xia, Zhengyuan , Sham, Pak C. , Kocher, Jean-Pierre A., Liu, Jun S. , Li, Miaoxin, Wang, Junwen , Pan, Zhicheng , Xu, Feng , Kocher, Jean-Pierre A., Wang, Junwen , Xia, Zhengyuan

Bioinformatics | June 7, 2016 | Volume: 32 | Issue: 18 | Pages: 2729-2736

10.1093/bioinformatics/btw288 Get It

Abstract Motivation: Prediction and prioritization of human non-coding regulatory variants is critical for understanding the regulatory mechanisms of disease pathogenesis and promoting personalized medicine. Existing tools utilize functional genomics data and evolutionary information to evaluate the pathogenicity or regulatory functions of non-coding variants. However, different algorithms lead to inconsistent and even conflicting predictions. Combining multiple methods may increase accuracy in regulatory variant prediction. Results: Here, we compiled an integrative resource for predictions from eight different tools on functional annotation of non-coding variants. We further developed a composite strategy to integrate multiple predictions and computed the composite likelihood of a given variant being regulatory variant. Benchmarked by multiple independent causal variants datasets, we demonstrated that our composite model significantly improves the prediction performance. Availability and Implementation: We implemented our model and scoring procedure as a tool, named PRVCS, which is freely available to academic and non-profit usage at http://jjwanglab.org/PRVCS. Contact: wang.junwen@mayo.edu, jliu@stat.harvard.edu, or limx54@gmail.com Supplementary information: Supplementary data are available at Bioinformatics online.